Showing results (161-170 of 389) with videos related to

Sort By:
Pageof 39
Current Alzheimer Research|February 23, 2016
Peripheral Immune Signatures in Alzheimer DiseaseDavid Goldeck, Jacek M Witkowski, Tamas Fülop, et al.
Immunity & Ageing : I & A|March 11, 2023
Natural IgG antibodies to β amyloid are decreased in patients with Parkinson's diseaseRoberto Paganelli, Alessia Paganelli, Graham Pawelec, et al.
Journal for Immunotherapy of Cancer|October 27, 2015
Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patientsJithendra Kini Bailur, Evelyna Derhovanessian, Brigitte Gueckel, et al.
Breast Cancer Research : BCR|April 8, 2015
Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patientsJithendra Kini Bailur, Brigitte Gueckel, Evelyna Derhovanessian, et al.
Nutrition Journal|October 14, 2011
Relationship between anthropometric variables and nutrient intake in apparently healthy male elderly individuals: a study from PakistanIftikhar Alam, Anis Larbi, Graham Pawelec, et al.
Mechanisms of Ageing and Development|March 4, 2006
Human cytomegalovirus infection and T cell immunosenescence: a mini reviewSven Koch, Rafael Solana, Olga Dela Rosa, et al.
Frontiers in Immunology|June 26, 2020
Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast CancerKilian Wistuba-Hamprecht, Cécile Gouttefangeas, Benjamin Weide, et al.
Journal of Proteome Research|October 25, 2017
Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular VesiclesKatherine R Adams, Sitara Chauhan, Divya B Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2016
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2Daniel W Beury, Kayla A Carter, Cassandra Nelson, et al.
The Journal of Experimental Medicine|December 21, 2005
A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillanceMasaki Terabe, Jeremy Swann, Elena Ambrosino, et al.
Pageof 39